中文 | English
Return
Total: 34 , 1/4
Show Home Prev Next End page: GO
MeSH:(TOR Serine-Threonine Kinases/antagonists )

4.Research progress of p70 ribosomal protein S6 kinase inhibitors.

Zhi-jun TU ; Gao-yun HU ; Qian-bin LI

Acta Pharmaceutica Sinica 2015;50(3):261-271

5.Mammalian target of rapamycin inhibitors for the targeted therapy of non-small cell lung cancer.

Yi LIN ; Li ZHANG

Acta Academiae Medicinae Sinicae 2010;32(2):239-242

6.Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1.

Ning LIU ; Ning XU ; Li-hui WEI ; Guo-lin CHAI

Chinese Medical Journal 2013;126(1):101-107

7.The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges.

Bianca CHEAIB ; Aurélie AUGUSTE ; Alexandra LEARY

Chinese Journal of Cancer 2015;34(1):4-16

8.Impact of genetic alterations on mTOR-targeted cancer therapy.

Shi-Yong SUN

Chinese Journal of Cancer 2013;32(5):270-274

9.Molecular mechanism of rhein on inhibiting autophagic protein expression in renal tubular epithelial cells via regulating mTOR signaling pathway activation.

Yue TU ; Wei SUN ; Liu-bao GU ; Yi-Gang WAN ; Hao HU ; Hong LIU

China Journal of Chinese Materia Medica 2014;39(21):4090-4095

10.Frontier of Epilepsy Research - mTOR signaling pathway.

Chang Hoon CHO

Experimental & Molecular Medicine 2011;43(5):231-274

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 34 , 1/4 Show Home Prev Next End page: GO